The stock of Co-Diagnostics Inc (CODX) has seen a 12.12% increase in the past week, with a -23.92% drop in the past month, and a -36.93% decrease in the past quarter. The volatility ratio for the week is 8.62%, and the volatility levels for the past 30 days are at 8.52% for CODX. The simple moving average for the past 20 days is -8.79% for CODX’s stock, with a -48.56% simple moving average for the past 200 days.
Is It Worth Investing in Co-Diagnostics Inc (NASDAQ: CODX) Right Now?
Moreover, the 36-month beta value for CODX is 1.03. Analysts have varying opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for CODX is 29.46M and currently, short sellers hold a 0.79% of that float. On March 07, 2025, CODX’s average trading volume was 208.05K shares.
CODX) stock’s latest price update
Co-Diagnostics Inc (NASDAQ: CODX)’s stock price has plunge by 8.04relation to previous closing price of 0.51. Nevertheless, the company has seen a 12.12% surge in its stock price over the last five trading sessions. prnewswire.com reported 2025-03-06 that SALT LAKE CITY, March 6, 2025 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that on March 4, 2025, the Securities & Governance Litigation Team at BakerHostetler, the legal firm retained to represent the Company, won complete dismissal on summary judgment of a Section 10(b) securities class action that had been pending against the Company in the United States District Court for the District of Utah. See Gelt Trading, Ltd.
Analysts’ Opinion of CODX
Many brokerage firms have already submitted their reports for CODX stocks, with Sidoti repeating the rating for CODX by listing it as a “Neutral.” The predicted price for CODX in the upcoming period, according to Sidoti is $5 based on the research report published on August 12, 2022 of the previous year 2022.
Sidoti, on the other hand, stated in their research note that they expect to see CODX reach a price target of $14. The rating they have provided for CODX stocks is “Buy” according to the report published on December 29th, 2021.
CODX Trading at -21.77% from the 50-Day Moving Average
After a stumble in the market that brought CODX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -75.11% of loss for the given period.
Volatility was left at 8.52%, however, over the last 30 days, the volatility rate increased by 8.62%, as shares sank -22.89% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -28.10% lower at present.
During the last 5 trading sessions, CODX rose by +6.04%, which changed the moving average for the period of 200-days by -51.84% in comparison to the 20-day moving average, which settled at $0.6071. In addition, Co-Diagnostics Inc saw -26.00% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for CODX
Current profitability levels for the company are sitting at:
- -9.26 for the present operating margin
- -0.02 for the gross margin
The net margin for Co-Diagnostics Inc stands at -8.96. The total capital return value is set at -0.64. Equity return is now at value -50.57, with -45.60 for asset returns.
Based on Co-Diagnostics Inc (CODX), the company’s capital structure generated 0.04 points at debt to capital in total, while cash flow to debt ratio is standing at -10.85. The debt to equity ratio resting at 0.04. The interest coverage ratio of the stock is -12.59.
Currently, EBITDA for the company is -41.48 million with net debt to EBITDA at 0.22. When we switch over and look at the enterprise to sales, we see a ratio of 1.98. The receivables turnover for the company is 25.86for trailing twelve months and the total asset turnover is 0.06. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.92.
Conclusion
To wrap up, the performance of Co-Diagnostics Inc (CODX) has been bad in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
